have called for the PBMs’ parent companies to be broken up. The FTC sued CVS Caremark, OptumRx and Express Scripts and their group purchasing organizations in September accusing the companies of ...
Express Scripts has gone to court to sue the FTC for defamation over the release of the first report, stating that it spent millions of dollars to provide data that the FTC staff seemed to ignore.
Express Scripts sued the commission two months after the first report, arguing that regulators had made unsubstantiated, false and biased claims about the industry. Three days later, the FTC sued ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
FTC commissioners voted unanimously to ... Two months later, the agency leaned on the report to sue Caremark, Express Scripts and Optum Rx — which jointly account for 80% of U.S. prescriptions ...
The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...
From 2017 to 2022, the companies — UnitedHealth Group's UNH.N Optum, CVS Health's CVS.N CVS Caremark and Cigna's CI.N Express Scripts ... for drugs. The FTC sued the three PBMs ...
From 2017 to 2022, the companies — UnitedHealth Group’s Optum, CVS Health’s CVS Caremark and Cigna’s Express Scripts ... pharmacies for drugs. The FTC sued the three PBMs in September ...
The FTC’s investigation into PBM practices ... Following that report, the agency sued Caremark, Express Scripts and Optum Rx, accusing the companies of artificially inflating insulin list ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal Trade Commission (FTC) uncovered in its second interim staff report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results